Literature DB >> 34785919

The Factors Influencing the Renal Glucose Threshold in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Shan-Shan Cui1, Li-Jun Duan1, Jun-Feng Li1, Yong-Zhang Qin2, Su-Qing Bao1, Xia Jiang1.   

Abstract

OBJECTIVE: This study aims to explore the factors influencing the renal glucose threshold (RTG) in patients with newly diagnosed type 2 diabetes mellitus (T2DM).
METHODS: A cross-sectional study was conducted on 1009 hospitalized patients with T2DM using stratified random sampling. Blood glucose was monitored using a dynamic blood glucose monitor to obtain the mean blood glucose (MBG), which is used to calculate the RTG. The factors influencing the RTG were then analyzed.
RESULTS: The mean RTG in patients with newly diagnosed T2DM was 203.58 ± 55.22 mg/dl. The correlation between the RTG and the various variables was analyzed, and the results demonstrated that the RTG was correlated with the patient's age (r = -0.14539, P = 0.0001); MBG (r = -0.35009, P = 0.0001); renal long neck (r = 0.16762, P = 0.0001); homeostatic model assessment for insulin resistance (r = -0.38322, P = 0.0001); homeostatic model assessment for beta-cell function (r = -0.22770, P = 0.0001); and the levels of glycated hemoglobin (HbA1c; r = 0.98994, P = 0.0001), blood urea nitrogen (r = -0.11093, P = 0.0004), creatinine (r = -0.26414, P = 0.0001), uric acid (r = -0.20149, P = 0.0001), total cholesterol (r = 0.13192, P = 0.0001), low-density lipoprotein (r = 0.12466, P = 0.0001), thyroid-stimulating hormone (r = -0.06346, P = 0.0460), beta-2 microglobulin (r = -0.08884, P = 0.0056), and 24-hour urine glucose (r = 0.32115, P = 0.0001). Multiple linear stepwise regression analysis revealed that the HbA1c, 24-hour urine glucose, estimated glomerular filtration rate (eGFR), D-dimer, and body mass index (BMI) should be included in the final model, and HbA1c had the greatest impact on the RTG followed in descending order by the 24-hour urine glucose, eGFR, D-dimer, and BMI (P < 0.05).
CONCLUSION: The RTG increases in most patients with newly diagnosed diabetes. The risk factors for the RTG are HbA1c, 24-hour urine glucose, eGFR, D-dimer, and BMI.
© 2021 Cui et al.

Entities:  

Keywords:  continuous glucose monitoring; newly diagnosed; renal glucose threshold; type 2 diabetes mellitus

Year:  2021        PMID: 34785919      PMCID: PMC8590450          DOI: 10.2147/DMSO.S336791

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  11 in total

1.  Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes--results of a hyperglycaemic glucose clamp study.

Authors:  Klaus Rave; Leszek Nosek; John Posner; Tim Heise; Kerstin Roggen; Ewoud-Jan van Hoogdalem
Journal:  Nephrol Dial Transplant       Date:  2006-04-20       Impact factor: 5.992

Review 2.  Glucose handling by the kidney.

Authors:  Amanda Mather; Carol Pollock
Journal:  Kidney Int Suppl       Date:  2011-03       Impact factor: 10.545

3.  Usefulness of urinary glucose excretion after oral glucose tolerance testing to detect insulin secretion failure before the onset of diabetes mellitus.

Authors:  Yosuke Ono; Sachiko Ono; Takashi Hinata; Toshimitsu Ito; Hiroko Yasuda; Yuji Tanaka
Journal:  Endocr J       Date:  2016-09-28       Impact factor: 2.349

Review 4.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

5.  Clinical usefulness of Glycated Albumin in the diagnosis of diabetes: Results from an Italian study.

Authors:  Chiara Bellia; Martina Zaninotto; Chiara Cosma; Luisa Agnello; Giulia Bivona; Mariela Marinova; Bruna Lo Sasso; Mario Plebani; Marcello Ciaccio
Journal:  Clin Biochem       Date:  2018-02-24       Impact factor: 3.281

6.  SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.

Authors:  Volker Vallon; Maria Gerasimova; Michael A Rose; Takahiro Masuda; Joseph Satriano; Eric Mayoux; Hermann Koepsell; Scott C Thomson; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-13

7.  Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.

Authors:  Sue Sha; Damayanthi Devineni; Atalanta Ghosh; David Polidori; Marcus Hompesch; Sabine Arnolds; Linda Morrow; Heike Spitzer; Keith Demarest; Paul Rothenberg
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 8.  Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.

Authors:  J E Gerich
Journal:  Diabet Med       Date:  2010-02       Impact factor: 4.359

9.  Characteristics and Impact Factors of Renal Threshold for Glucose Excretion in Patients with Type 2 Diabetes Mellitus.

Authors:  Xiao Dan Yue; Jing Yu Wang; Xin Rong Zhang; Ju Hong Yang; Chun Yan Shan; Miao Yan Zheng; Hui Zhu Ren; Yi Zhang; Shao Hua Yang; Zhen Hong Guo; Bai Chang; Bao Cheng Chang
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

10.  Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes.

Authors:  Ralph A DeFronzo; Marcus Hompesch; Sreeneeranj Kasichayanula; Xiaoni Liu; Ying Hong; Marc Pfister; Linda A Morrow; Bruce R Leslie; David W Boulton; Agatha Ching; Frank P LaCreta; Steven C Griffen
Journal:  Diabetes Care       Date:  2013-06-04       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.